Evaluation of early ischemic change using ASPECTS and intravenous rt-PA therapy-Reference-Cited by-同舟云学术

Evaluation of early ischemic change using ASPECTS and intravenous rt-PA therapy

Published:2015 Issue:5 Volume:37 Page:347-351
ISSN:0912-0726
Container-title:Nosotchu
language:en
Short-container-title:Jpn. J. Stroke

Author:

Hirano Teruyuki¹²

Affiliation:

1. Department of Neurology, Oita University Faculty of Medicine

2. (Department of Stroke and Cerebrovascular Medicine, Kyorin University)

Publisher

Japan Stroke Society

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jstroke/37/5/37_10298/_pdf

Reference19 articles.

1. 2) Minematsu K, Toyoda K, Hirano T, et al: Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society. J Stroke Cerebrovasc Dis 22: 571–600, 2013

2. 3) Hirano T, Yonehara T, Inatomi Y, et al: Presence of early ischemic changes on computed tomography depends on severity and the duration of hypoperfusion: a single photon emission-computed tomographic study. Stroke 36: 2601–2608, 2005

3. 4) Pexman JH, Barber PA, Hill MD, et al: Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol 22: 1534–1542, 2001

4. 5) Barber PA, Demchuk AM, Zhang J, et al: Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 355: 1670–1674, 2000

5. 6) Demchuk AM, Hill MD, Barber PA, et al: Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 36: 2110–2115, 2005